Lyell Immunopharma, Inc.LYELNASDAQ
Loading
Income Before Tax Over TimeContracting
Percentile Rank17
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-274.45M
↓ 19% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-231.32M
Historical baseline
PeriodValueYoY Change
TTM$-274.45M+20.0%
2024$-342.99M-46.2%
2023$-234.63M-28.1%
2022$-183.12M+26.8%
2021$-250.22M-22.4%
2020$-204.47M-58.0%
2019$-129.38M-